Overview of MET Amplification and MET Exon 14 Skipping Mutations in NSCLC
Giuseppe Giaccone, MD, PhD, discusses alterations in the MET gene that can be oncogenic drivers in patients with non–small cell lung cancer.
Tepotinib Effective for MET+ NSCLC Found by Tissue or Liquid Biopsy
Giuseppe Giaccone, MD, PhD, discusses the results of the VISION trial of tepotinib in patients with non–small cell lung cancer.